Sorafenib enriches EpCAM positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.

D X Guan, Jimin Shi, Yingxin Zhang, J S Zhao, L Y Long, Tian Wu Chen, E B Zhang,Yuan Yuan Feng, W D Bao, Y Z Deng,Lili Qiu, X L Zhang,H P Koeffler, J J Li, Shijie Cheng, Di Xie

Hepatology（2015）

Cited 23|Views10

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined